Health-focused software CancerAid has entered the United States market after closing deals that will link its thousands of users to the database of renowned Los Angeles hospital Cedars-Sinai and the services offered by tech giant Apple.
CancerAid serves as a digital tool for cancer patients to keep track of the symptoms they experience on a daily basis. The app also provides support by collecting a wide array of educational resources about cancer and keeping users' medical history records. CancerAid users can also join an online community with other patients who use the app and receive notifications on the latest news about cancer research.
According to reports, CancerAid will provide comprehensive services to its users now that it has established a partnership with Epic Systems, the electronic medical record system that provides services to Cedars-Sinai.
The partnership between CancerAid and Cedars-Sinai means that cancer patients who use the app can immediately share the data they enter into the app and onto their doctors’ database.
“Integrating into the healthcare providers’ workflow is crucial when you’re trying to improve clinical practice in digital health. … Integrating into a large health system can be difficult and our product team have done a wonderful job of navigating those challenges,” CancerAid CTO Andrew Harvey said in a statement (via Healthcare IT).
CancerAid co-founder Nikhil Pooviah told TechCrunch in an email statement, “Patients will be able to use the patient-facing app at home, with a feedback loop back to their care team (physicians, nurses) in the hospital in real-time. This feedback loop helps reduce [emergency room] visits and 30-day readmissions (saving $19,000 per patient per year).”
Meanwhile, CancerAid’s partnership with Apple will be manifested through wearable devices like the Apple Watch, according to TechCrunch.
Right now, CancerAid’s regular app users are reportedly about 20,000.


Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
SoftBank and Intel Partner to Develop Next-Generation Memory Chips for AI Data Centers
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Nvidia Confirms Major OpenAI Investment Amid AI Funding Race
Sam Altman Reaffirms OpenAI’s Long-Term Commitment to NVIDIA Amid Chip Report
Instagram Outage Disrupts Thousands of U.S. Users
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Elon Musk’s Empire: SpaceX, Tesla, and xAI Merger Talks Spark Investor Debate
SpaceX Updates Starlink Privacy Policy to Allow AI Training as xAI Merger Talks and IPO Loom
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate 



